Cognition Therapeutics Inc (NAS:CGTX)
$ 1.07 +0.066 (+6.65%) Market Cap: 95.76 Mil Enterprise Value: 63.50 Mil PE Ratio: 0 PB Ratio: 3.12 GF Score: 35/100

Cognition Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 17, 2026 / 01:00PM GMT
Release Date Price: $1.42 (+12.70%)
Operator

Thank you for standing by, and welcome to the Cognition Therapeutics Meeting. I will now turn the call over to Lisa Ricciardi.

Lisa Ricciardi
Cognition Therapeutics Inc - President, Chief Executive Officer, Director

Thank you. Good morning, everyone. I'd like to officially call the meeting to order and welcome all of you to the 2026 Annual Meeting of Stockholders of Cognition Therapeutics. My name is Lisa Ricciardi. I'm the Chief Executive Officer, President, and Director, and I will be presiding at this meeting. Let me turn to introductions. This year, we're holding our Annual Meeting in an all-virtual format. We believe this format enables maximum stockholder participation by offering our stockholders the same opportunities to participate as would have. Available in an in-person meeting, along with increased accessibility. We appreciate your participation today.

Now, before proceeding to the business of the meeting, I would like to introduce our directors and members of our management team. In addition to myself, the following members of the Board

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot